Azamian Bobak R.

President/CEO and Board Chair

Azamian Bobak R. has filed 8 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.

On the most recent filing, Azamian Bobak R. is listed as President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. Inside the rolling window, Azamian Bobak R. reported no open-market purchases and 8 open-market sales totaling $5.5M in TARS. The largest disclosed transaction in the window is a sale of 10,000 TARS shares on Sep 4, 2026, worth $906K.

Companies traded

Other insiders at TARS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$5.5M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TARSSale$906KSep 9SEC ↗
TARSSale$801KSep 3SEC ↗
TARSSale$615KJun 22SEC ↗
TARSSale$762KMar 19SEC ↗
TARSSale$802KMar 19SEC ↗
TARSSale$802KMar 19SEC ↗
TARSSale$495KDec 30SEC ↗
TARSSale$332KSep 26SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Azamian Bobak R. made?

Azamian Bobak R. has filed 8 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.

Which companies does Azamian Bobak R. trade?

Azamian Bobak R. has filed SEC Form 4 disclosures for 1 company, including TARS.

When was Azamian Bobak R.'s most recent SEC Form 4 filing?

Azamian Bobak R.'s most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.

What is Azamian Bobak R.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Azamian Bobak R. is listed as President/CEO and Board Chair.

What is Azamian Bobak R.'s total buy and sell value in the current window?

Inside the rolling retention window, Azamian Bobak R. bought $0 and sold $5.5M based on SEC Form 4 filings.

What was Azamian Bobak R.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,000 TARS shares on 2026-09-04, worth $906K, per SEC Form 4 filings.